IL85576A0 - Activated rnase l as a marker for virus infections - Google Patents

Activated rnase l as a marker for virus infections

Info

Publication number
IL85576A0
IL85576A0 IL85576A IL8557688A IL85576A0 IL 85576 A0 IL85576 A0 IL 85576A0 IL 85576 A IL85576 A IL 85576A IL 8557688 A IL8557688 A IL 8557688A IL 85576 A0 IL85576 A0 IL 85576A0
Authority
IL
Israel
Prior art keywords
pathway
rnase
aids
biochemical
inhibitor
Prior art date
Application number
IL85576A
Other languages
English (en)
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of IL85576A0 publication Critical patent/IL85576A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL85576A 1987-03-03 1988-02-29 Activated rnase l as a marker for virus infections IL85576A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2137287A 1987-03-03 1987-03-03

Publications (1)

Publication Number Publication Date
IL85576A0 true IL85576A0 (en) 1988-08-31

Family

ID=21803819

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85576A IL85576A0 (en) 1987-03-03 1988-02-29 Activated rnase l as a marker for virus infections

Country Status (20)

Country Link
EP (1) EP0285263B1 (fr)
JP (1) JPH0675520B2 (fr)
KR (1) KR880011593A (fr)
AT (1) ATE107964T1 (fr)
AU (1) AU618525B2 (fr)
CA (1) CA1337278C (fr)
DE (1) DE3850428T2 (fr)
DK (1) DK112888A (fr)
ES (1) ES2058252T3 (fr)
FI (1) FI880959A7 (fr)
IE (1) IE66831B1 (fr)
IL (1) IL85576A0 (fr)
MX (1) MX173802B (fr)
NO (1) NO880934L (fr)
NZ (1) NZ223721A (fr)
OA (1) OA08720A (fr)
PH (1) PH30882A (fr)
PT (1) PT86878B (fr)
RU (1) RU2049336C1 (fr)
ZA (1) ZA881471B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306347B1 (fr) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnostic des déficiences en RNA double-brin
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
AU724056B2 (en) * 1987-09-04 2000-09-14 Hem Research, Inc. Diagnosis and treatment of double stranded deficiency states
ES2066847T3 (es) * 1988-07-07 1995-03-16 Hem Pharma Corp Diagnostico y tratamiento del sindrome de fatiga cronica.
US5985565A (en) 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6080554A (en) * 1999-04-27 2000-06-27 R.E.D. Laboratories, N.V. Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
RU2202110C1 (ru) * 2001-07-26 2003-04-10 Научно-исследовательский испытательный центр (медико-биологической защиты) Государственного научно-исследовательского испытательного института военной медицины МО РФ Способ определения активности и функционального состояния синтетазы оксида азота
WO2017193051A1 (fr) * 2016-05-06 2017-11-09 The Trustees Of Princeton University Procédés de surveillance de l'activité de rnase l

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
DE3850428T2 (de) 1994-11-24
PT86878B (pt) 1992-05-29
NO880934D0 (no) 1988-03-02
AU1256388A (en) 1988-09-01
PT86878A (pt) 1988-04-01
ZA881471B (en) 1988-12-28
EP0285263A2 (fr) 1988-10-05
CA1337278C (fr) 1995-10-10
NO880934L (no) 1988-09-05
KR880011593A (ko) 1988-10-29
MX173802B (es) 1994-03-29
ATE107964T1 (de) 1994-07-15
OA08720A (en) 1989-03-31
IE66831B1 (en) 1996-02-07
EP0285263B1 (fr) 1994-06-29
RU2049336C1 (ru) 1995-11-27
PH30882A (en) 1997-12-23
JPH0675520B2 (ja) 1994-09-28
NZ223721A (en) 1991-02-26
EP0285263A3 (en) 1990-04-18
FI880959A0 (fi) 1988-03-02
ES2058252T3 (es) 1994-11-01
DK112888D0 (da) 1988-03-02
FI880959A7 (fi) 1988-09-04
DK112888A (da) 1988-09-04
AU618525B2 (en) 1992-01-02
JPS63309200A (ja) 1988-12-16
DE3850428D1 (de) 1994-08-04
IE880587L (en) 1988-09-03

Similar Documents

Publication Publication Date Title
EP0285263A3 (en) Activated rnase l as a marker for virus infections
AU6497694A (en) Method for selective inactivation of viral replication
GB2199328A (en) Translation of mrna
YU48323B (sh) Postupak za dobijanje askorbinske kiseline
WO1993017651A3 (fr) Analogues nucleosidiques antiviraux, leur fabrication et leur utilisation
FI883763A0 (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
SE8601435D0 (sv) Aktivt pansar
IL85603A (en) Synergistic compositions of interleukin-2 and mismatched double- stranded rna
IE892060L (en) Antiviral combinations
MX9303709A (es) Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene.
ES2000853A6 (es) Proyectil portador para mortero
DE69324244D1 (de) Therapeutische nukleoside der 2',3'-dideoxy-3'-fluor -purin reihe
GB1484836A (en) Mineral carriers grafted by silicon and adenine radicals
EP0034424A3 (fr) Composés contenant un noyau à sept chainons, comme inhibiteurs de cytidine déaminase
DE60128565D1 (en) Polycyclische xanthone als antibiotika
EP0335770A3 (fr) Dérivés de nucléotides de fluorophosphonates
WO1988007080A3 (fr) Cellules animales transgeniques resistantes aux infections virales
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
AR247215A1 (es) Un procedimiento para producir un antibiotico antifungico y antiviral, n-acetilbenanomicina b.
SE8702004D0 (sv) Rotasjonsprosjektil med et hult neseparti
ES8405381A1 (es) Un procedimiento para preparar compuestos derivados de 1,3,5-triacrilhexahidro-s-triazina.
EP0124884A3 (fr) Allumeur actionné par devant
NO985112L (no) Eksplosivformuleringer